People Briefs: JenaValve CEO; Ortho-Clinical Changes; Baxter CFOs
This article was originally published in The Gray Sheet
Executive Summary
JenaValve Technology names David Drachman as CEO. Ortho-Clinical Diagnostics makes executive changes following split from J&J. Baxter plans a CFO switch when it completes its biopharmaceutical company spinoff next year. More people news.